| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00001756-199710200-00007 |
| P8608 | Fatcat ID | release_vb4cvqolungtbfn73t5nqwvviq |
| P698 | PubMed publication ID | 9351646 |
| P2093 | author name string | Massi P | |
| Parolaro D | |||
| Rubino T | |||
| Viganò D | |||
| Tizzoni L | |||
| P433 | issue | 15 | |
| P921 | main subject | morphine | Q81225 |
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 3219-3223 | |
| P577 | publication date | 1997-10-01 | |
| P1433 | published in | NeuroReport | Q15710007 |
| P1476 | title | Modulation of rat brain cannabinoid receptors after chronic morphine treatment | |
| P478 | volume | 8 |
| Q35035878 | Addictive potential of cannabinoids: the underlying neurobiology |
| Q41038624 | Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists. |
| Q48924387 | Behavioral sensitization to WIN55212.2 in rats pretreated with heroin |
| Q35047694 | CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat |
| Q31863511 | Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse |
| Q33637224 | Cannabinoid-opioid interactions during neuropathic pain and analgesia |
| Q30807024 | Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data |
| Q44189376 | Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine |
| Q43890403 | Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels |
| Q33186390 | Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. |
| Q43657067 | Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects |
| Q36007619 | Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray |
| Q48470538 | Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? |
| Q30373359 | Endocannabinoid signalling in reward and addiction. |
| Q43691633 | Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice |
| Q39401349 | Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain |
| Q43662870 | Functional interaction between opioid and cannabinoid receptors in drug self-administration. |
| Q50152394 | Hyperphagia in pre-fed rats following oral delta9-THC. |
| Q73223400 | In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments |
| Q73840320 | Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome |
| Q39363705 | Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems |
| Q42539758 | Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats |
| Q33677066 | Pharmacological and biochemical interactions between opioids and cannabinoids. |
| Q37345505 | Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception |
| Q34939968 | Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. |
| Q37646423 | The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. |
| Q51415189 | Two distinctive antinociceptive systems in rats with pathological pain. |
Search more.